Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound

byiShook Opinion
Nov 26, 2024 - 11:05

Share

Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound. The post Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound appeared first on Investor's Business Daily.

Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound.

The post Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound appeared first on Investor's Business Daily.